Schneider News - A3LJTV

Novo Nordisk Makes Victoza(R) Commercially Available in the United States

PRINCETON, N.J., Feb. 16 /PRNewswire-FirstCall/ -- Novo Nordisk (NYSE: NVO) today announced that Victoza® (liraglutide [rDNA origin] injection...

Novo Nordisk Makes FORTUNE's List of '100 Best Companies to Work For'

Second Consecutive Year for Diabetes Care Leader PRINCETON, N.J., Jan. 21 /PRNewswire-FirstCall/ -- Novo Nordisk, a global healthcare company...

Diabetes and Pre-Diabetes Accounted for $218 Billion in Costs in 2007, Health Affairs Paper Demonstrates

- Novo Nordisk-Funded Analysis Underscores Need to Address Spiraling Diabetes Cost - PRINCETON, N.J., Jan. 14 /PRNewswire/ -- A new analysis...

/K I L L K I L L K I L L - National Changing Diabetes Program/

We are advised by National Changing Diabetes Program that journalists and other readers should disregard the news release, Diabetes and...

Diabetes and Pre-Diabetes Accounted for $218 Billion in Costs in 2007, Health Affairs Paper Demonstrates

- Novo Nordisk-Funded Analysis Underscores Need to Address Spiraling Diabetes Cost - PRINCETON, N.J., Jan. 13 /PRNewswire/ -- A new analysis...

FDA Approves 10 mcg Dose of Vagifem(R) for the Treatment of Atrophic Vaginitis Due to Menopause

Study Shows Relief of Postmenopausal Symptoms PRINCETON, N.J., Dec. 2 /PRNewswire-FirstCall/ -- Novo Nordisk said today that the U.S. Food and...

Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows

Findings Underscore Urgent Need to Reform CBO Scoring of Preventive Care PRINCETON, N.J., Nov. 27 /PRNewswire/ -- The diabetes population in the...

Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows

Findings Underscore Urgent Need to Reform CBO Scoring of Preventive Care PRINCETON, N.J., Nov. 27 /PRNewswire/ -- The diabetes population in the...

Doctors Cite Time, Low Reimbursement As Barriers To Providing Comprehensive Diabetes Care, Survey Results Show

Primary Care Doctors, Endocrinologists Feel Ill-Equipped to Provide Ideal, Multi-Disciplinary Team Care PRINCETON, N.J., Nov. 19 /PRNewswire/...

Novo Nordisk is Changing Possibilities in Hemophilia

Expanded Web Site and Facebook Wall Provide Resources to Hemophilia with Inhibitors Community PRINCETON, N.J., Oct. 30 /PRNewswire-FirstCall/...

Data Analysis Reinforces the Safety Profile of Levemir(R)

PRINCETON, N.J., Oct. 20 /PRNewswire-FirstCall/ -- A meta-analysis of clinical data published today in Diabetologia, the medical journal for the...

Research Supports Improving 'Scoring' of Costs and Benefits of Preventive Health Care to Better Inform Federal Budgetary Decisio

Current federal models estimating the cost of preventive care may underestimate true benefit of upfront investment in chronic illnesses PRINCETON...

National Changing Diabetes Program Supports Improvements in Health Cost Estimates

Preventive Health Savings Act and Health Affairs report agree Congress needs better cost estimates to assess health policies WASHINGTON, Sept. 1...

Patient Education Summits to Address Special Challenges of Hemophilia Patients and Their Families

Novo Nordisk Helps Provide Unique Opportunity for Patients to Connect and Learn from Others with the Disease PRINCETON, N.J., Aug. 27...

Dwayne Johnson, Novo Nordisk and the Entertainment Industry Foundation Educate Families about Healthy Living and Diabetes

Johnson Asks Families to be Diabetes Aware in New Public Service Announcement PRINCETON, N.J. and LOS ANGELES, Aug. 12 /PRNewswire/ -- Dwayne...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Schneider (A3LJTV)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

A3LJTV News

Novo Nordisk Makes Victoza(R) Commercially Available in the United States

Novo Nordisk Makes FORTUNE's List of '100 Best Companies to Work For'

Diabetes and Pre-Diabetes Accounted for $218 Billion in Costs in 2007, Health Affairs Paper Demonstrates

/K I L L K I L L K I L L - National Changing Diabetes Program/

Diabetes and Pre-Diabetes Accounted for $218 Billion in Costs in 2007, Health Affairs Paper Demonstrates

FDA Approves 10 mcg Dose of Vagifem(R) for the Treatment of Atrophic Vaginitis Due to Menopause

Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows

Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows

Doctors Cite Time, Low Reimbursement As Barriers To Providing Comprehensive Diabetes Care, Survey Results Show

Novo Nordisk is Changing Possibilities in Hemophilia

Data Analysis Reinforces the Safety Profile of Levemir(R)

Research Supports Improving 'Scoring' of Costs and Benefits of Preventive Health Care to Better Inform Federal Budgetary Decisio

National Changing Diabetes Program Supports Improvements in Health Cost Estimates

Patient Education Summits to Address Special Challenges of Hemophilia Patients and Their Families

Dwayne Johnson, Novo Nordisk and the Entertainment Industry Foundation Educate Families about Healthy Living and Diabetes

A3LJTV Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Schneider (A3LJTV) News

Schneider (A3LJTV)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

A3LJTV News

Novo Nordisk Makes Victoza(R) Commercially Available in the United States

Novo Nordisk Makes FORTUNE's List of '100 Best Companies to Work For'

Diabetes and Pre-Diabetes Accounted for $218 Billion in Costs in 2007, Health Affairs Paper Demonstrates

/K I L L K I L L K I L L - National Changing Diabetes Program/

Diabetes and Pre-Diabetes Accounted for $218 Billion in Costs in 2007, Health Affairs Paper Demonstrates

FDA Approves 10 mcg Dose of Vagifem(R) for the Treatment of Atrophic Vaginitis Due to Menopause

Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows

Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows

Doctors Cite Time, Low Reimbursement As Barriers To Providing Comprehensive Diabetes Care, Survey Results Show

Novo Nordisk is Changing Possibilities in Hemophilia

Data Analysis Reinforces the Safety Profile of Levemir(R)

Research Supports Improving 'Scoring' of Costs and Benefits of Preventive Health Care to Better Inform Federal Budgetary Decisio

National Changing Diabetes Program Supports Improvements in Health Cost Estimates

Patient Education Summits to Address Special Challenges of Hemophilia Patients and Their Families

Dwayne Johnson, Novo Nordisk and the Entertainment Industry Foundation Educate Families about Healthy Living and Diabetes

A3LJTV Discussion

Your Recent History